Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz;Tumeurs secondaires après traitement pour maladie de Hodgkin en Tunisie. Étude rétrospective à propos de 26 cas observés à l'institut Salah-Azaïz

Cancer/Radiotherapie

Volumn 7, Issue 5, 2003, Pages 302-307

  Kochbati, L ^a   Boussen, H ^a   Benna, F ^a   Belhaj Ali, Z ^b   Gammoudi, A ^a   Bouaouina, N ^c   Besbes, M ^a   Ghilen, L ^a   Rahal, K ^a   Maalej, M ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b Hopital Aziza Othmana   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Chemotherapy; Hodgkin; Radiotherapy; Second cancer

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CISPLATIN; COBALT 60; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SECOND CANCER; TREATMENT OUTCOME; TUNISIA;

EID: 0142057230     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00081-7     Document Type: Article

References (29)

1. Aisenberg AC. Probems in Hodgkin's disease management. Blood 1999;93:761-79.
2. Armitage JO. Long-term toxicity of the treatment of Hodgkin's disease. Ann Oncol 1998;9:133-6.
3. Bay JO, Uhrhammer N, Stoppa-Lyonnet D, Hall J. Rôle du gène ATM dans la prédisposition génétique aux cancers. Bull Cancer 2000;87:29-34.
4. Bhatia S, Robison L, Oberlin O, Greenberg M, Buwin G, Fossati-Bellani F, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-51.
5. Boivin JF, O'Brien K. Solid cancer risk after treatment of Hodgkin's disease. Cancer 1988;61:2541-6.
6. Boussen H, Gritli S, Touati S, Chebbi A, Krichen H, Benna F, et al. Ostéosarcome secondaire de la tête et du cou après traitement pour carcinome indifférencié du cavum. Bull cancer 1997;84:1115-8.
7. Boussen H, Kochbati L, Besbes M, Dhiad T, Makhlouf R, Jerbi G, et al. Cancer du sein chez l'homme après traitement pour maladie de Hodgkin : à propos d'un cas et revue de la littérature. Cancer/Radiother 2000;4:465-8.
8. Buchholz TA, Wu X. Radiation-induced chromatic breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys 2001;49:533-7.
9. Cappelaere P. Les lymphomes non-hodgkiniens secondaires. Bull Cancer 1998;85:217-31.
10. Chauveinc L, Lefevre S, Malfoy B, Dutrillaux B. Actualités sur les tumeurs radio-induites : les études génétiques. Bull Cancer 2002;89:181-96.
11. Cutuli B, De la Rochefordiere A, Dhermain F, Graic Y, de Lafontan B, Dilhuydy JM, et al. Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinicohistologiques et possibilités thérapeutiques : analyse de 13 cas. Cancer/Radiother 1997;1:300-6.
12. Dores GM, Metayer C, Curtis E, Lynch CF, Clarke EA, Glemeluis B, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
13. Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, et al. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathological and features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys 2001;49:539-46.
14. Goss PE, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol 1998;16:338-47.
15. Henry-Amar M, Gisselbrecht C. Complications tardives des traitements de la maladie de Hodgkin. Rev Prat 1998;48:1092-7.
16. Kaldor J, Lasset C. Second malignancies following Hodgkin's disease. In: Sommer R, Henri Ammar M, Meerwald J, Carde P, editors. Treatment strategy in Hodgkin's disease. Paris: Inserm/John Libbey Eurotext; 1990. p. 139-50.
17. Kochbati L, Boussen H, Gritli S, Besbes M, Benama S, Saadi A, et al. Fibrosarcome secondaire de la mandibule après chimioradiothérapie pour carcinome indifférencié du nasopharynx. À propos d'une observation et revue de la littérature. Cancer/Radiother 2001;5:283-6.
18. Leis AA, Fratkin J. Chandrosarcoma of the spine and thyroid carcinoma following radiation therapy for Hodgkin's lymphoma. Neurology 1997;48:1710-2.
19. Mattson A, Ruden B, Palmgren J, Rutqvist L. Dose and time response for breast cancer risk after radiation therapy for benign disease. Br J Cancer 1995;72:1054-61.
20. Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002 Sep 15;20:3765-71.
21. Neugut AL, Murray T, Santos J, Arnols H, Hayes MK, Flannery JT, et al. Increased risk of lung cancer after breast cancer radiation in cigarette smokers. Cancer 1994;73:1615-20.
22. Nyandoto P, Muhonen T, Joensuu H. Second cancer among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 1998;42:373-8.
23. Rueffer U, Josting A, Franklin J, May M, Sieber M, Breuer K, et al. NHL after primary Hodgkin's disease' in the German Hodgkin lymphoma study group: incidence, treatment and prognosis. J Clin Oncol 2001;19:2026-32.
24. Shah AB, Hudson MM, Poquette CA, Luo X, Wiliams JA, Kun LE. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at Saint-Jude Children's Research Hospital. Int J Radiat Oncol Biol Phys 1999;44:867-77.
25. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ. Second malignacy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 1997;75:116-23.
26. Tarbell NJ, Gelber RD, Weinstein HJ, Mauch P, et al. Sex differences in risk second malignant tumours after Hodgkin's disease in childhood. Lancet 1993;341:1428-32.
27. Van Leeuwen FE, Klokman WJ, Van't Veer B, Hagenbeek A, Krol AD, Vetter VA, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000;18:487-97.
28. Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 1998;16:536-44.
29. Yahalom J, Petrek JA, Biddinger Pw, Kessler S, Dershaw DD, Mc Cormick B, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathological analysis of 45 events in 37 patients. J Clin Oncol 1992;10:1647-81.